JP5870775B2 - 錠剤及びその製造方法 - Google Patents

錠剤及びその製造方法 Download PDF

Info

Publication number
JP5870775B2
JP5870775B2 JP2012052531A JP2012052531A JP5870775B2 JP 5870775 B2 JP5870775 B2 JP 5870775B2 JP 2012052531 A JP2012052531 A JP 2012052531A JP 2012052531 A JP2012052531 A JP 2012052531A JP 5870775 B2 JP5870775 B2 JP 5870775B2
Authority
JP
Japan
Prior art keywords
component
dry
tablet
components
disintegration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2012052531A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012250974A (ja
Inventor
和裕 石田
和裕 石田
文仁 内藤
文仁 内藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lion Corp
Original Assignee
Lion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corp filed Critical Lion Corp
Priority to JP2012052531A priority Critical patent/JP5870775B2/ja
Publication of JP2012250974A publication Critical patent/JP2012250974A/ja
Application granted granted Critical
Publication of JP5870775B2 publication Critical patent/JP5870775B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2012052531A 2011-05-11 2012-03-09 錠剤及びその製造方法 Active JP5870775B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012052531A JP5870775B2 (ja) 2011-05-11 2012-03-09 錠剤及びその製造方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011105950 2011-05-11
JP2011105950 2011-05-11
JP2012052531A JP5870775B2 (ja) 2011-05-11 2012-03-09 錠剤及びその製造方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015231308A Division JP6090610B2 (ja) 2011-05-11 2015-11-27 錠剤の製造方法

Publications (2)

Publication Number Publication Date
JP2012250974A JP2012250974A (ja) 2012-12-20
JP5870775B2 true JP5870775B2 (ja) 2016-03-01

Family

ID=47524127

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012052531A Active JP5870775B2 (ja) 2011-05-11 2012-03-09 錠剤及びその製造方法
JP2015231308A Active JP6090610B2 (ja) 2011-05-11 2015-11-27 錠剤の製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015231308A Active JP6090610B2 (ja) 2011-05-11 2015-11-27 錠剤の製造方法

Country Status (2)

Country Link
JP (2) JP5870775B2 (ko)
KR (1) KR101900106B1 (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014129238A (ja) * 2012-12-28 2014-07-10 Lion Corp エトドラク含有固形製剤
JP6051059B2 (ja) * 2013-01-23 2016-12-21 ライオン株式会社 エトドラク含有粒子及びエトドラク含有固形製剤
JP6245756B2 (ja) * 2013-05-21 2017-12-13 ライオン株式会社 内服用コーティング錠剤
JP6326114B2 (ja) * 2016-11-01 2018-05-16 エルメッド エーザイ株式会社 レベチラセタム含有医薬組成物及びその製造方法、並びにレベチラセタム含有医薬組成物の崩壊及び溶出の少なくともいずれかの遅延防止方法、及びレベチラセタム含有医薬組成物の崩壊及び溶出の少なくともいずれかの遅延防止剤
WO2019093434A1 (ja) * 2017-11-09 2019-05-16 日本臓器製薬株式会社 アセトアミノフェン製剤及びその製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1227626B (it) * 1988-11-28 1991-04-23 Vectorpharma Int Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
JP2007314529A (ja) * 2006-04-28 2007-12-06 Lion Corp 造粒粒子、錠剤、及び造粒粒子の製造方法
JP5434213B2 (ja) * 2009-04-09 2014-03-05 ライオン株式会社 イブプロフェン含有固形物及びその製造方法、ならびにイブプロフェン含有固形物を配合してなるイブプロフェン製剤

Also Published As

Publication number Publication date
JP6090610B2 (ja) 2017-03-08
JP2012250974A (ja) 2012-12-20
JP2016053079A (ja) 2016-04-14
KR101900106B1 (ko) 2018-09-18
KR20120127259A (ko) 2012-11-21

Similar Documents

Publication Publication Date Title
JP6090610B2 (ja) 錠剤の製造方法
JP4965130B2 (ja) 乾式直打速崩壊性錠剤
JP4707073B2 (ja) アトルバスタチン経口投与用粒子状医薬組成物
JP2013544849A (ja) 迅速分散顆粒、口腔内崩壊錠、および方法
JP2003516341A (ja) 治療薬
AU2011244020A1 (en) Method for preparing pharmaceutical compositions intended for oral administration comprising one or more active ingredients and the compositions comprising same
JP6433066B2 (ja) 錠剤及びその製造方法
JP5974469B2 (ja) 錠剤の製造方法
JP5810819B2 (ja) 積層錠
JP2013136526A (ja) 口腔内崩壊錠及びその製造方法
JP6015116B2 (ja) 錠剤及びその製造方法
TWI468189B (zh) Oral internal disintegrating tablet and its manufacturing method
JP7250305B2 (ja) メマンチン又はその薬物学的に許容される塩を含む医薬組成物及びその製造方法
JP6552088B2 (ja) 造粒顆粒およびその製造方法と、錠剤およびその製造方法
JP6407084B2 (ja) 錠剤およびその製造方法
JP6037824B2 (ja) エトドラク含有固形製剤
JP6198329B2 (ja) 積層錠及びその製造方法
WO2013062073A1 (ja) 低用量ラモセトロン含有口腔内崩壊錠
JP2021107337A (ja) 内服医薬製剤及び固形医薬製剤
TW202220643A (zh) 含有米羅巴林苯磺酸鹽之口腔內崩散錠
JP2020026433A (ja) 固形製剤の製造方法
WO2014157603A1 (ja) 経口投与用医薬組成物
JP2021102609A (ja) 医薬組成物
AU2020215141A1 (en) Orodispersible tablet
JP2017132716A (ja) 錠剤の製造方法

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20141105

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150929

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151127

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20151215

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20151228

R150 Certificate of patent or registration of utility model

Ref document number: 5870775

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350